Paneni Francesco, Costantino Sarah, Cosentino Francesco
*Cardiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
Clin Sci (Lond). 2015 Jan;128(2):69-79. doi: 10.1042/CS20140302.
The incidence of stroke and myocardial infarction increases in aged patients and it is associated with an adverse outcome. Considering the aging population and the increasing incidence of cardiovascular disease, the prediction for population well-being and health economics is daunting. Accordingly, there is an unmet need to focus on fundamental processes underlying vascular aging. A better understanding of the pathways leading to arterial aging may contribute to design mechanism-based therapeutic approaches to prevent or attenuate features of vascular senescence. In the present review, we discuss advances in the pathophysiology of age-related vascular dysfunction including nitric oxide signalling, dysregulation of oxidant/inflammatory genes, epigenetic modifications and mechanisms of vascular calcification as well as insights into vascular repair. Such an overview highlights attractive molecular targets for the prevention of age-driven vascular disease.
中风和心肌梗死的发病率在老年患者中增加,且与不良预后相关。鉴于人口老龄化以及心血管疾病发病率的上升,对人群健康和健康经济学的预测令人望而生畏。因此,迫切需要关注血管衰老的基本过程。更好地理解导致动脉衰老的途径可能有助于设计基于机制的治疗方法,以预防或减轻血管衰老的特征。在本综述中,我们讨论了与年龄相关的血管功能障碍的病理生理学进展,包括一氧化氮信号传导、氧化/炎症基因的失调、表观遗传修饰和血管钙化机制以及对血管修复的见解。这样的概述突出了预防年龄驱动的血管疾病的有吸引力的分子靶点。